Clinical Trial Update: A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis

View source ↗

Summary

This ClinicalTrials.gov update indicates that the study evaluating ozanimod for ulcerative colitis has been terminated, reporting on utilization, effectiveness,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Zeposia (ozanimod hydrochloride)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Colitis, Ulcerative | Status: TERMINATED